CALR and rheumatoid arthritis: The prevalence of anti‐CRT Ab in IIM patients was significantly higher than that in HC (17.3% vs. 1.2%, P = 0.008), but was not significantly different to that in SLE, RA and pSS patients (all P > 0.05).